ALS-FUS突变导致异常的PARylation和基因素H1.2相互作用,导致病理变化
Hafiza Alirzayeva1, Rute Loureiro1, Seda Koyuncu1
1Institute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, 50931 Cologne, Germany; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Cell reports
|August 21, 2024
概括
在肌缩侧硬化症 (ALS) 中,突变FUS蛋白聚合因组素H1.2和PARP1.1而恶化. 减少这些因素可以缓解运动神经元退化,这表明FUS-ALS的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种神经退行性疾病,具有与FUS基因突变相关的严重早期发病形式.
- 突变FUS蛋白聚合在压力颗粒中,破坏细胞过程并推动疾病的进展.
研究的目的:
- 为了研究人类运动神经元中FUSP525L突变的分子相互作用.
- 通过了解突变FUS聚合的机制来确定FUS-ALS的潜在治疗点.
主要方法:
- 在iPSC衍生的运动神经元中对FUSP525L相互作用体进行蛋白质组学分析.
- 研究PARP1,多ADP-ribosylation (PARylation) 和基因素H1.2在FUS-ALS病变发生过程中的作用.
- 使用C. elegans模型来验证体内发现的结果.
主要成果:
- 突变FUSP525L与PARP1相互作用,增加PARylation,并结合于素H1.2.2.
- 抑制PARylation或降低H1.2水平可以改善FUS聚合,压力颗粒异常和运动神经元中的亡.
- 过度表达H1.2会加剧FUS-ALS表型,而在C. elegans中抑制H1.2和PARP1的正统表达会减少神经退行.
结论:
- 在FUS-ALS.病变发生过程中,PARylation,基因素H1.2和FUS之间存在一种新的联系.
- 准PARylation通路和H1.2可能为FUS-ALS提供治疗策略.
相关概念视频
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mutations
81.2K
Overview
81.2K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K


